You fail to understand two things:
1. The fact remains that Vericel completed a Phase 2b study. Your repeated insistence that they completed three different Phase 2 trials does not change that fact.
2. Where did I say or even imply that primary endpoints were not met? Seriously.
3. No, you have not provided a balanced view and no you don't need to be sorry as it does not bother me one bit.
So knock yourself out with your self-aggrandizing commentary that keeps going off target and is pointless. SMH.
MSB Price at posting:
$2.33 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)